Nuklearmedizin. Nuclear medicine

Psycho-Oncological Screening Identifies High-Risk Subgroups Among Neuroendocrine Tumor Patients Undergoing PRRT with [177Lu]Lu-DOTATATE: Implications for Survival.

Pub Date : 2025-06-30 DOI: 10.1055/a-2641-7759 Barbara Kreppel, Hannah M Jochims, Milka Marinova, Jim Küppers, Ingo G H Schmidt-Wolf, Georg Feldmann, Maria Angeles Gonzalez-Carmona, Markus Essler

Correction: Divergent growth on [18F]FDG PET/CT in a case of co-existing pulmonary metastatic leiomyosarcoma and papillary thyroid carcinoma.

Pub Date : 2025-06-01 DOI: 10.1055/a-2286-9571 Sean Ira G Gacula, Sophie C Kunte, Lena M Unterrainer, Johannes Rübenthaler, Wolfgang G Kunz, Clemens Cyran, Adrien Holzgreve

FAPI PET/CT provides higher uptake and better target to back ground in recurrent and metastatic tumors of patients with Iodine refractory papillary thyroid cancer compared with FDG PET CT.

Pub Date : 2025-06-01 DOI: 10.1055/a-2185-7746 Shaghayegh Nourbakhsh, Yalda Salehi, Saeed Farzanehfar, Reza Ghaletaki, Mohsen Bakhshi Kashi, Mehrshad Abbasi